No connection

Search Results

SURG

BEARISH
$0.66 Live
SurgePays, Inc. · NASDAQ
Target $5.0 (+655.3%)
$0.46 52W Range $3.47

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 20, 2026
Market cap
$16.63M
P/E
N/A
ROE
N/A
Profit margin
-63.3%
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
SURG exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -0.91, indicating negative shareholder equity. While the company shows impressive top-line revenue growth of 68.70%, it is fundamentally broken, reporting a negative gross margin of -18.59%, meaning it loses money on every dollar of revenue generated. Severe liquidity risk is evident with a current ratio of 0.38, and a consistent track record of missing earnings estimates (0/4 in the last year) suggests a complete disconnect between analyst projections and operational reality.

Key Strengths

Strong YoY revenue growth of 68.70%
Strong Q/Q revenue growth of 68.67%
Very low Price-to-Sales ratio (0.29)
Low PEG ratio (0.48) based on forward projections
Single analyst maintains a highly optimistic target price of $5.00

Key Risks

Negative equity (P/B -0.91) indicating insolvency risk
Negative gross margins (-18.59%) showing an unsustainable business model
Severe liquidity crisis with a current ratio of 0.38
Catastrophic price performance (-73.4% over 1 year)
Consistent and massive earnings misses (Avg surprise -192.65%)

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
11
Weak
Value
15
Future
30
Past
5
Health
5
Dividend
0
AI Verdict
Distressed Asset
Key drivers: Negative Book Value, Piotroski F-Score 1/9, Negative Gross Margins, Liquidity Crisis
Confidence
90%
Value
15/100

P/S is deceptive because the company is not profitable at the gross level.

Positives
  • Low P/S ratio
Watchpoints
  • Negative P/B ratio
  • No Graham Number available due to negative earnings/equity
Future
30/100

Revenue growth is irrelevant if gross margins remain negative.

Positives
  • High revenue growth
Watchpoints
  • Unable to convert growth into profit
  • Consistent earnings misses
Past
5/100

Long-term trend is a steady decline in value.

Positives
No standout positives identified.
Watchpoints
  • 94% loss over 5 years
  • Consistent failure to meet EPS estimates
Health
5/100

Company is in a state of severe financial fragility.

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score 1/9
  • Current Ratio 0.38
  • ROA -117.95%
Dividend
0/100

Dividend strength is 0/100.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • No capacity to pay

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.66
Analyst Target
$5.0
Upside/Downside
+655.3%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for SURG and closest competitors.

Updated 2026-04-17
SUR
SurgePays, Inc.
Primary
5Y
-94.0%
3Y
-85.8%
1Y
-73.4%
6M
-75.8%
1M
-22.8%
1W
-1.2%
GIG
GigaMedia Limited
Peer
5Y
-57.4%
3Y
-5.7%
1Y
-13.6%
6M
-18.9%
1M
-14.2%
1W
-7.0%
DLP
Dolphin Entertainment, Inc.
Peer
5Y
-93.9%
3Y
-60.4%
1Y
+76.4%
6M
+2.3%
1M
-5.8%
1W
+4.4%
MSG
Motorsport Games Inc.
Peer
5Y
-98.2%
3Y
-32.5%
1Y
+344.3%
6M
+66.1%
1M
-17.3%
1W
-0.3%
CHA
Core AI Holdings
Peer
5Y
-100.0%
3Y
-100.0%
1Y
-84.3%
6M
-88.0%
1M
-47.4%
1W
0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
11.03
PEG Ratio
0.48
P/B Ratio
-0.91
P/S Ratio
0.29
EV/Revenue
0.45
EV/EBITDA
-0.87
Market Cap
$16.63M

Profitability

Profit margins and return metrics

Profit Margin -63.32%
Operating Margin -57.57%
Gross Margin -18.59%
ROE N/A
ROA -117.95%

Growth

Revenue and earnings growth rates

Revenue Growth +68.7%
Earnings Growth N/A
Q/Q Revenue Growth +68.67%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
0.38
Weak
Quick Ratio
0.32
Poor
Cash/Share
$0.08

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
-14.8%
Op. Margin
-57.6%
Net Margin
-85.6%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$-0.0B
Debt/Equity
-1.56x
Operating CF
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
100%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-12
$N/A
2026-04-13
$-0.69
-331.2% surprise
2025-11-11
$-0.38
-162.1% surprise
2025-08-13
$-0.36
-84.6% surprise

Communication Services Sector Comparison

Comparing SURG against 149 companies in the Communication Services sector (14 bullish, 40 neutral, 95 bearish)
Profit Margin
-63.32%
This Stock
vs
-5.95%
Sector Avg
+964.5% (Superior)
Revenue Growth
68.7%
This Stock
vs
694.84%
Sector Avg
-90.1% (Slower)
Current Ratio
0.38
This Stock
vs
2.36
Sector Avg
-83.8% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

COX KEVIN BRIAN
Chief Executive Officer
Stock Award
2026-04-01
1,300,000 shares · $707,520
COX KEVIN BRIAN
Chief Executive Officer
Gift
2026-03-24
270,745 shares
EVERS ANTHONY GEORGE
Chief Financial Officer
Stock Award
2025-12-31
200,000 shares
MAY DAVID ALLEN
Director
Buy
2025-12-10
38,422 shares · $61,647
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
1 analysts
Ascendiant Capital
2026-04-17
Maintains
Buy Buy
Ascendiant Capital
2025-12-22
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning SURG from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile